Clinical Trial Update: DURABILITY+ : a Prospective, Multi-center, Controlled Study With the Everflex+ Stent in SFA Lesions [Phase 4]

View source ↗

Summary

The DURABILITY+ trial, a multicenter, controlled Phase 4 study of the Everflex+ peripheral arterial stent in superficial femoral artery lesions for peripheral a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Everflex+ Stent (peripheral arterial stent)

Snippet

Sponsor: Flanders Medical Research Program | Conditions: Peripheral Arterial Disease | Phase 4 | Status: COMPLETED